In CSCs, NAMPT regulates epithelial-mesenchymal transition (EMT) and tumor dedifferentiation/reprograming via controlling cellular functions that promote proliferation and pathways mediated by SIRT1 and PARP1 [116]. The gene discussed is PARP1; the disease is neoplasm.